NasdaqCM - Delayed Quote USD

INVO Bioscience, Inc. (INVO)

1.1700 -0.1300 (-10.00%)
At close: April 24 at 4:00 PM EDT
1.0600 -0.11 (-9.40%)
After hours: April 24 at 7:57 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Steven M. Shum CEO & Director 260k -- 1971
Mr. Andrea Goren Chief Financial Officer 215k -- 1967
Mr. Michael Jos. Campbell COO & VP of Business Development 220k -- 1958
Mr. Bojan Mitrovic Ph.D. Director of Sales US -- -- --
Mr. Robert Joseph Bowdring Jr. Treasurer & Secretary -- -- 1958
Ms. Terah Krigsvold Controller -- -- --

INVO Bioscience, Inc.

5582 Broadcast Court
Sarasota, FL 34240
United States
978 878 9505 https://www.invobio.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
25

Description

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Corporate Governance

INVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 13, 2024 - May 17, 2024
INVO Bioscience, Inc. Earnings Call

Related Tickers